RhumbLine Advisers’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
RhumbLine Advisers's MXCT Position: Q3 2026 in Review
RhumbLine Advisers sold out of MaxCyte (MXCT) in Q3 2026, closing a stake of 47,973 shares — an estimated $59K sold.
RhumbLine Advisers first reported a position in MXCT in Q3 2021 and held it in 20 quarters. The position peaked at $955K in Q4 2021. 120 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.
- RhumbLine Advisers reported no remaining MaxCyte position as of Q3 2026 after selling out during the quarter.
- RhumbLine Advisers sold 47,973 MaxCyte shares in Q3 2026, an estimated $59K.
- RhumbLine Advisers first reported a position in MaxCyte in Q3 2021 and held it in 20 quarters.
- RhumbLine Advisers's MaxCyte position peaked at $955K in Q4 2021.
- 120 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.